1. AstraZeneca, Lilly, Sanofi, and others raise prices to start July — Merck gets a CRL from FDA on Keytruda for hepatocellular carcinoma — 2020 biotech IPOs continue to break records — See more on our front page news Stay updated with the latest pharma-related coronavirus news on our new page
    Dismiss Notice
  2. Please take our quick survey on how COVID-19 is impacting your job It will only take a minute or two to respond. The survey is confidential, and does not require registration. Thank you in advance for your participation. We will provide regular updates on results as responses accumulate.
    Dismiss Notice

Status of GI Allergan-abbvie merger

Discussion in 'Allergan' started by anonymous, Jul 5, 2019 at 1:40 PM.

Tags: Add Tags
  1. anonymous

    anonymous Guest

    There is an overlap product with GI in Allergan and Abbvie. Will they sell off Zenpep before the acquisition and let people go then? When and would it be Zenpep or creon folks?
     

  2. anonymous

    anonymous Guest

    Abbvie people stay and Allergan people are fired. That’s all you need to know
     
  3. anonymous

    anonymous Guest

    We (Allergan GI) are gonna be hit hard if not obliterated. Any DM with Allergan is most likely fired and primary care will take a big hit too. Those are all obvious though
     
  4. anonymous

    anonymous Guest

    Not sure why everyone assumes the GI team is done just because of zenpep. Linzess is the GI flagship product and still remains. GI is supposed to launch ubrogepant. Just depends on the direction they take. We'll just have to wait and see.
     
  5. anonymous

    anonymous Guest


    Allergan has to divest Zenpep BEFORE the deal closes.

    That leaves Linzess, which Allergan only has partial ownership, and Viberzi which is a total dog that has barely been promoted.
     
  6. anonymous

    anonymous Guest

    Hahaha just like all the other Abbott /abbvie deals abbvie throws their own to the wolves
     
  7. anonymous

    anonymous Guest

    Not sure what will happen this time but I can tell you from the KOS experience...It was a bloodbath for Abbott Reps.
     
  8. anonymous

    anonymous Guest

    Correct me if I’m wrong but doesnt Abbvie already have 3 different GI teams: hep C, humira for Crohns/colitis, and the creon team in GI, PC, and CF? They've been in GI for years and those reps have longevity. Not sure what that means for either company.
     
  9. anonymous

    anonymous Guest

    It means they don’t need Allergan GI twos not managers lmao.

    Allergan only co-promotes LZ which we can do easily in their place. And anybody can promote Viberzi that’s already at Abbie even though it’s a loser drug that nobody wants to talk about
     
  10. anonymous

    anonymous Guest

    “Combined SG&A for the two companies was $11.7B in 2018. An $800M reduction represents less than 7% of the total, which is again a fairly small amount which should be easily achievable. If anything, we should expect a higher amount of synergies here.”
    Most likely from Allergan GI and PCR. On the call to investors, Rick G made it seem pretty clear Abbvie employees will be kept as much as possible. Allergan offers a great 52 week severance no matter your years of service. Hope for the best prepare for the worst. Gang gang!
     
  11. anonymous

    anonymous Guest

    Based on past acquisition and mergers it means all the component Abvie representatives will be fired and Forest reps will replace them
     
  12. anonymous

    anonymous Guest

    Forest what, who??? Bye
     
  13. anonymous

    anonymous Guest

    So what happens if Syneos reps get hired as a GI specialty rep before the deal closes. You think they get Severance if laid off?
     
  14. anonymous

    anonymous Guest

    Uh, no. Probably not. Syneos gets whatever is in their contract.
     
  15. anonymous

    anonymous Guest

    interviews through syneos are next week. Supposedly syneos was reassured that GI would remain a concern after deal goes through since GI is profitable. Currently the strategy is to focus on selling zenpep, Linzess and ultimately will be trained on all products for syneos reps. Recruiter said AGN's plan is to merge neuro and GI together-which doesn't make sense
     
  16. anonymous

    anonymous Guest

    Pretty sure brazikumab and Zenpep must be sold in order for deal to close. The recruiter is blowing smoke up your a**.
     
  17. anonymous

    anonymous Guest

    What else is new
     
  18. anonymous

    anonymous Guest

    Interviewing for Allergan GI position this Friday through Syneos. What is the honest opinion of this position? Leaving current company due to sales force being turned into part time positions and want to find something more secure/full time. Honest feedback appreciated
     
  19. anonymous

    anonymous Guest

    Nothing in Pharma is secure or guaranteed. Direct hire or contract. No guarantees!
     
  20. anonymous

    anonymous Guest

    To the poster leaving because the positions are being turned into part-time ones; who do you work for? I used to have a part-time position and sometimes think about returning to part time. Thanks!